B-Phage
PrivateTotal Funding Raised
$406,000
Company Overview
B-Phage operates in Healthcare & Life Sciences and is based in Cape Town. It has raised $406,000.
B-Phage is a biotechnology company developing AI-driven bacteriophage therapeutics to combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
B-Phage Comparables
Compare B-Phage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phiogen | 84% | |
| PhageAI S.A. | 79% | |
| Tolka AI Therapeutics | 78% |
For institutional investors. Book with your work email.
B-Phage Funding Rounds
Historical fundraising activity
B-Phage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneBio Venture Studio | Pre Seed |
B-Phage Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about B-Phage's valuation, stock price, and market status.
Is B-Phage a public or private company?
B-Phage is a private company.
What is the current stock price of B-Phage?
B-Phage is a private company, so its shares have no public market price. Caplight tracks B-Phage's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is B-Phage worth (valuation)?
Valuation information for B-Phage is not publicly available.
Can I buy B-Phage stock?
B-Phage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was B-Phage's last funding round?
Funding round information for B-Phage is not publicly available.
Who are the main investors in B-Phage?
Key investors in B-Phage include OneBio Venture Studio.
Will B-Phage IPO soon?
No public IPO plans have been announced for B-Phage.
How can I track B-Phage secondary market activity?
Caplight tracks bids, offers, and trades in B-Phage's shares on secondary markets.